Low Performance of a Clinical-Genetic Model in the Estimation of Time in Therapeutic Range in Acenocoumarol-Adherent Patients With Nonvalvular Atrial Fibrillation: The Quality of Anticoagulation Challenge

BioMed Research International - United States
doi 10.1155/2018/8012747